Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: from pathology to treatment.
about
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial.Phase II trial of dacomitinib in patients with HER2-positive gastric cancer.IMP3 expression in gastric cancer: association with clinicopathological features and HER2 status.
P2860
Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: from pathology to treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Her-2/neu gene amplification a ...... : from pathology to treatment.
@en
Her-2/neu gene amplification a ...... : from pathology to treatment.
@nl
type
label
Her-2/neu gene amplification a ...... : from pathology to treatment.
@en
Her-2/neu gene amplification a ...... : from pathology to treatment.
@nl
prefLabel
Her-2/neu gene amplification a ...... : from pathology to treatment.
@en
Her-2/neu gene amplification a ...... : from pathology to treatment.
@nl
P2093
P1476
Her-2/neu gene amplification a ...... a: from pathology to treatment
@en
P2093
Christiane M R Thallinger
Christoph C Zielinski
Judith Maresch
Michael Hejna
P304
P356
10.1016/J.CRITREVONC.2011.06.003
P577
2011-07-23T00:00:00Z